CN104208532A - Drug for treating erythrodermic psoriasis - Google Patents
Drug for treating erythrodermic psoriasis Download PDFInfo
- Publication number
- CN104208532A CN104208532A CN201410471579.XA CN201410471579A CN104208532A CN 104208532 A CN104208532 A CN 104208532A CN 201410471579 A CN201410471579 A CN 201410471579A CN 104208532 A CN104208532 A CN 104208532A
- Authority
- CN
- China
- Prior art keywords
- radix
- treatment
- erythrodermic psoriasis
- patients
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug for treating erythrodermic psoriasis. Capsule products are prepared through uniformly mixing the following raw pharmaceutical materials in parts by weight: 15-25g of buffalo horn, 25-35g of raw rehmannia root, 10-14g of radix paeoniae rubra, 10-14g of cortex moutan, 10-20g of salvia miltiorrhiza, 10-20g of radix scrophulariae, 10-14g of phellodendron bark, 25-35g of rhizoma smilacis glabrae, 8-12 of peach kernel and 10-20g of angelica root, then, extracting active ingredients from the traditional Chinese medicines, adding water to decoct for 3 times, decocting for 0.5-1 hour every time, combining decoctions of the three times, filtrating, concentrating into thick paste, of which the relative density at the temperature of 60 DEG C is 1.25-1.3, drying at the temperature of 50-60 DEG C, then, crushing into medicine powder, of which the size is 100 meshes, encapsulating, sterilizing and disinfecting. The weight of the product per capsule is 1.5g. The drug disclosed by the invention has the effects of clearing away heat and toxic materials, cooling and replenishing blood, promoting blood circulation and dispelling blood stasis and clearing spots and eliminating measles, and has the characteristics of fast treatment effect, short treatment course and no side effect during the treatment of erythrodermic psoriasis; after the drug disclosed by the invention is taken orally by 120 patients for 5 treatment courses, 96 patients are cured, the conditions of 12 patients are improved, the treatment for 12 patients is invalid, the effective rate is 90%, and the cure rate is 80%. During medication, no adverse reaction is caused.
Description
Technical field
The present invention relates to one and treat psoriatic medicine, specifically, is a kind of medicine for the treatment of erythrodermic psoriasis.
Background technology
Erythrodermic psoriasis is a kind of special types of psoriasis involving whole body most skin, but sickness rate is minimum in psoriasis.Erythrodermic psoriasis is often secondary to some unmanageable psoriasis in plaques.There is periodically far-ranging skin rubefaction in patient, and sick illing skin is often with serious desquamation and Pruritus pain.As everyone knows, erythrodermic psoriasis is very thorny disease, and patient's medicine injection flower a lot of money all can not be cured completely, makes patient feel bad very much misery.Have the medicine of a lot for the treatment of erythrodermic psoriasis at present, but curative effect is undesirable, price is also high, causes financial burden to patient.
Summary of the invention
The invention solves the deficiencies in the prior art, provide the medicine of a kind of short treating period, treatment erythrodermic psoriasis evident in efficacy.
Medicine of the present invention is prepared by the crude drug of following ratio of weight and number:
Cornu Bubali 15-25 Radix Rehmanniae 25-35 Radix Paeoniae Rubra 10-14 Cortex Moutan 10-14
Radix Salviae Miltiorrhizae 10-20g Radix Scrophulariae 10-20 Cortex Phellodendri 10-14 Rhizoma Smilacis Glabrae 25-35
Semen Persicae 8-12 Flos Carthami 8-12 Radix Angelicae Sinensis 10-20.
The preferred weight mark of described crude drug is:
Cornu Bubali 20g Radix Rehmanniae 30g Radix Paeoniae Rubra 12g Cortex Moutan 12g
Radix Salviae Miltiorrhizae 15g Radix Scrophulariae 15g Cortex Phellodendri 12g Rhizoma Smilacis Glabrae 30g
Semen Persicae 10g Flos Carthami 10g Radix Angelicae Sinensis 15g.
By above-mentioned various Chinese medicine according to after described ratio of weight and number mix homogeneously, decoct with water 3 times, each 0.5 ~ 1 hour, merge 3 decocting liquids, filter, being condensed into 60 DEG C of relative densities is the thick paste of 1.25 ~ 1.3, after 50 ~ 60 DEG C of dryings, be crushed to 100 object medicated powder, in incapsulating, sterilization obtains capsule product.
According to tcm treatment according to syndrome differentiation, erythroderma can be divided into scorchingly hotly to pent up, pyretic toxicity holds wet and intenseness of heat impairment of YIN card under the arm, in prescription of the present invention, Cornu Bubali, Rhizoma Smilacis Glabrae heat-clearing and toxic substances removing blood cooling and ecchymoses removing are monarch; The Radix Rehmanniae, Radix Paeoniae Rubra, Cortex Moutan, Radix Angelicae Sinensis removing heat from blood nourish blood as minister; Cortex Phellodendri, Radix Scrophulariae replenishing YIN and removing heat are assistant; Radix Salviae Miltiorrhizae, Semen Persicae, Flos Carthami blood circulation promoting and blood stasis dispelling are for making.Each medicine share and gathers heat-clearing and toxic substances removing altogether, and removing heat from blood benefit blood, blood circulation promoting and blood stasis dispelling, clear speckle moves back the merit of rash.Prescription of the present invention carrys out compatibility for the mechanism of Chinese traditional treatment erythrodermic psoriasis, has significant curative effect to treatment erythrodermic psoriasis.
For investigating the clinical efficacy of Drug therapy erythrodermic psoriasis of the present invention further, 120 routine erythrodermic psoriasis patients are selected to carry out clinical observation on the therapeutic effect.
Clinical data:
Select outpatient 120 example, wherein man 80 example, female 40 example, the course of disease May ~ 3 years, 15 ~ 75 years old age.
Diagnostic criteria
Can diagnosis be made according to morbidity history, clinical symptoms, medication treatment history and lab testing:
(1) can be sent out in any age, but be many with person in middle and old age, male, more than women, accounts for psoriatic's about 1%.The whole body of patient or most skin generation flushing and a large amount of desquamations, original homeliness type typical case skin lesion all disappears, or on the small pieces normal skin that only can carry at some, sees the typical skin lesion of minority;
(2) can there is the decortication of bulk in hands and foot.Just as the glove be torn are the same with socks.Refer to the muddiness of (toe) first change, thicken, be even badly deformed and come off.Whole body pruritus is obvious, and often with symptoms such as fever, headache and general malaises;
(3) there is heating before acute onset person dermexanthesis, shiver with cold, the reaction in early stage such as asthenia more.Erythra onset extremity of being everlasting bend body side or a small amount of erythema occurs the face of bending, joint, rapid spread to whole body, in flushing, then a large amount of desquamation widely.Head And Face, because sebum is more or infection causes squama thicker, can connects together with hair, generally can cause alopecia;
(4) pachyonychia, uneven, sallow, comes off eventually.Pharynx, nasal mucosa also can be got involved.Normal with lymphadenectasis.Laboratory checks: can find leukocytosis, and in blood, oxyphil cell raises, and blood ammonia is than GPS survey 3 to 7 times, and total serum protein amount reduces, and albumin reduces and gamma globulin increases, and patient with severe symptoms there will be abnormal liver function.
Therapeutic Method
Oral medicine of the present invention, one time 5, one day twice, sooner or later each once.
Criterion of therapeutical effect
Clinical recovery: erythema skin lesion all disappears or disappear area >90%;
Effective: erythema skin lesion disappears area 61% ~ 90%;
Progressive: erythema skin lesion disappears area 21% ~ 60%;
Invalid: erythema skin lesion disappears area≤20%.
Therapeutic outcome
120 routine patient's oral administration Drug therapy 5 of the present invention course for the treatment of, cure 96 examples, 12 examples that take a turn for the better, invalid 12 examples, effective percentage 90%, cure rate 80%.Period in a medicine, has no adverse reaction.
Model case
Case one: Korea Spro so-and-so, male, 45 years old.The scaling erythra recurrent exerbation of main cause whole body 1 year half, increases the weight of January on April 23rd, 2010 and goes to a doctor.Before 1 year half there is the squamous papule be dispersed in patient without obvious inducement bilateral ancon, clear border, strikes off squama red color visible thin film and petechial hemorrhage, and part can disappear voluntarily.But recurrent exerbation, the heavy summer in winter is light, and skin lesion increases gradually, expands.In succession there is similar skin lesion in scalp and extremity, without rotten to the corn, sepage.Once many places out-patient treatment, has certain curative effect.Before January, the two lower limb of patient and the both hands back of the body occur that again new skin lesion is gone to a doctor.Patient mental's appetite is good, and defecation and sleep are normally.Have a medical check-up: body temperature 36.4 DEG C, face dolorosa.The no positive sign of cardiopulmonary abdomen.Training checks: the squamous papule that scalp and extremity are dispersed in as seen, and be many with two lower limb especially, clear border, symmetrical, substrate flushing, there is silvery white squama on surface, strikes off squama red color visible thin film and petechial hemorrhage.Conscious pruritus is obvious.Be diagnosed as erythrodermic psoriasis.Give erythrodermic psoriasis medicine, after treating May, erythra all disappears, clinical recovery.
Case two: Lv, male, 30 years old.The scaling erythra recurrent exerbation of main cause whole body 15 years, increases the weight of July on August 15th, 2011 and goes to a doctor.Patient before 15 years because pressure causes insomnia greatly, there is the squamous papule that two lower limb are dispersed in thereupon, with pruritus, increase gradually later, expand, partial fusion is in blocks, in succession there is similar skin lesion in trunk and extremity, without rotten to the corn, sepage, once repeatedly arrived the diagnosis and treatment of the ground such as Taiyuan, Yuncheng, oral methoxy dish purine has certain curative effect, but recurrent exerbation, the heavy summer in winter is light.Before July, skin lesion increases the weight of, and two forearm and bilateral shank skin lesion merge in flakes, substrate flushing, and inflammatory infiltration is obvious, and pruritus is significantly medical.Patient mental's appetite still can, defecation and sleep normal.Have a medical check-up: body temperature 36.7 DEG C, face dolorosa.The no positive sign of cardiopulmonary abdomen.Skin training checks: the squamous papule that trunk and extremity are dispersed in, speckle, and clear border is symmetrical, substrate flushing, and inflammatory infiltration is obvious, and there is a small amount of silvery white squama on surface, strikes off squama without obvious red pigment and petechial hemorrhage; Bilateral shank skin lesion merges in flakes, and conscious pruritus is remarkable.Be diagnosed as psoriasis.Give the medicine of erythrodermic psoriasis, after treating June, erythra all disappears, clinical recovery.
Case three: Shen so-and-so, man, 30 years old.Main cause whole body general lamellar squama speckle 5 years, increases the weight of July and within 1st, goes to a doctor in JIUYUE in 2013.Patient caught a cold before 15 years, and transfusion is rear finds that pimple, the squama speckle of kermesinus Sorghum vulgare Pers. size appear in the whole body, consciously slightly to itch, do not draw attention, after a few days, skin lesion Progressive symmetric erythrokeratodermia increases the weight of, once took traditional Chinese medicine and the treatment such as Western medicine methotrexate Tripterygium wilfordii Polyglycosidium Tablets, recurrent exerbation, skin lesion is extended to coin shape gradually.The heavy summer in winter is light.After cause cat fever in July, above-mentioned symptom increases the weight of to go to a doctor in my institute.Have a medical check-up: body temperature 37.4 DEG C, normal face.The no positive sign of cardiopulmonary abdomen.Skin training checks: skin lesion is that palm is large.Two lower limb skin lesion map shape, two have a little normal skin island below knee between erubescence, companion infiltrates, and smooth surface is shinny and come off with furfur sample canescence squama.Both legs swelling.Be diagnosed as " erythrodermic psoriasis ", take cattle erythrodermic psoriasis medicine, after July, skin rash all disappears clinical recovery.
Case four: grandson so-and-so, women, 26 years old.The scaling erythra recurrent exerbation of main cause whole body 3 years, increases the weight of February on November 12nd, 2012 and goes to a doctor.The squamous papule that two lower limb are dispersed in is there is after patient suffered from cold before 3 years, with pruritus, increase gradually later, expand, partial fusion is in blocks, and similar skin lesion appears in trunk and extremity in succession, without rotten to the corn, sepage, once the diagnosis and treatment of the ground such as Taiyuan, Yuncheng were repeatedly arrived, oral methoxy dish purine has certain curative effect, but recurrent exerbation, the heavy summer in winter is light.Before February, skin lesion increases the weight of, and two forearm and bilateral shank skin lesion merge in flakes, substrate flushing, and inflammatory infiltration is obvious, and pruritus is significantly medical.Patient mental's appetite still can, defecation and sleep normal.Have a medical check-up: body temperature 36.7 DEG C, face dolorosa.The no positive sign of cardiopulmonary abdomen.Training checks: the squamous papule that trunk and extremity are dispersed in, speckle, and clear border is symmetrical, substrate flushing, and inflammatory infiltration is obvious, and there is a small amount of silvery white squama on surface, strikes off squama without obvious red pigment and petechial hemorrhage; Two forearm and bilateral shank skin lesion merge in flakes, and conscious pruritus is remarkable.Be diagnosed as erythrodermic psoriasis.Give erythrodermic psoriasis medicine, after treating April, erythra all disappears, clinical recovery.
Case five: Yan so-and-so, female, 27 years old, workman.Main cause ictal whole body pimple, squama speckle 5 years, increase the weight of January on June 10th, 2012 and go to a doctor.Patient before 5 years because of mood smooth after find that pimple, the squama speckle of kermesinus Sorghum vulgare Pers. size appear in the whole body, consciously slightly itch, do not draw attention, after a few days, skin lesion Progressive symmetric erythrokeratodermia increases the weight of, and takes a turn for the better after my Out-patient Department oral Chinese medicine treatment, afterwards mood smooth after recurrence.Before January, above-mentioned symptom increases the weight of to go to a doctor in my institute again.Have a medical check-up: body temperature 37.4 DEG C, normal face.The no positive sign of cardiopulmonary abdomen.Skin training checks: whole body skin kermesinus Sorghum vulgare Pers. or larger pimple, squama speckle, substrate peony.The visible silvery white micaceous scales of grabbing comes off, whole body xerosis cutis, coarse, extremity more so, visible filbert fish scale-shaped squama.Be diagnosed as erythrodermic psoriasis.Give erythrodermic psoriasis medicine, after treating April, skin rash all disappears, clinical recovery.
Case six: in so-and-so, female, 12 years old.The scaling erythra recurrent exerbation of main cause whole body 2 years, increases the weight of to go to a doctor on January 17th, 2012 for 15 days.There is without obvious inducement the squamous papule that two lower limb are dispersed in patient before 2 years, with pruritus, increase gradually later, expand, partial fusion is in blocks, and similar skin lesion appears in trunk and extremity in succession, without rotten to the corn, sepage, once the diagnosis and treatment of the ground such as Taiyuan, Yuncheng were repeatedly arrived, oral methoxy dish purine has certain curative effect, but recurrent exerbation, the heavy summer in winter is light.Before 15 days, skin lesion increases the weight of, and two forearm and bilateral shank skin lesion merge in flakes, substrate flushing, and inflammatory infiltration is obvious, and pruritus is significantly medical.Patient mental's appetite still can, defecation and sleep normal.Have a medical check-up: body temperature 36.7 DEG C, the no positive sign of cardiopulmonary abdomen.Training checks: the squamous papule that trunk and extremity are dispersed in, speckle, and clear border is symmetrical, substrate flushing, and inflammatory infiltration is obvious, and there is a small amount of silvery white squama on surface, strikes off squama without obvious red pigment and petechial hemorrhage; Two forearm and bilateral shank skin lesion merge in flakes, and conscious pruritus is remarkable.Be diagnosed as erythrodermic psoriasis.Give erythrodermic psoriasis medicine, after treating February, erythra all disappears, clinical recovery.
Detailed description of the invention
Embodiment 1
Take removing impurity, after the Cornu Bubali 15g cleaned up, Radix Rehmanniae 25g, Radix Paeoniae Rubra 10g, Cortex Moutan 10g, Radix Salviae Miltiorrhizae 10g, Radix Scrophulariae 10g, Cortex Phellodendri 10g, Rhizoma Smilacis Glabrae 25g, Semen Persicae 8g, Flos Carthami 8g, Radix Angelicae Sinensis 10g mix homogeneously, extract the active component of Chinese medicine, decoct with water 3 times, each 0.5 ~ 1 hour, merge 3 decocting liquids, filter, being condensed into 60 DEG C of relative densities is the thick paste of 1.25 ~ 1.3, after 50 ~ 60 DEG C of dryings, be crushed to 100 object medicated powder, in incapsulating, sterilization obtains capsule product.This product every is heavy 1.5 grams.
Using method: oral medicine of the present invention, one time 5, one day twice, sooner or later each once.
Embodiment 2
Take removing impurity, after the Cornu Bubali 20g cleaned up, Radix Rehmanniae 30g, Radix Paeoniae Rubra 12g, Cortex Moutan 12g, Radix Salviae Miltiorrhizae 15g, Radix Scrophulariae 15g, Cortex Phellodendri 12g, Rhizoma Smilacis Glabrae 30g, Semen Persicae 10g, Flos Carthami 10g, Radix Angelicae Sinensis 15g mix homogeneously, extract the active component of Chinese medicine, decoct with water 3 times, each 0.5 ~ 1 hour, merge 3 decocting liquids, filter, being condensed into 60 DEG C of relative densities is the thick paste of 1.25 ~ 1.3, after 50 ~ 60 DEG C of dryings, be crushed to 100 object medicated powder, in incapsulating, sterilization obtains capsule product.This product every is heavy 1.5 grams.
Using method: oral medicine of the present invention, one time 5, one day twice, sooner or later each once.
Embodiment 3
Take removing impurity, after the Cornu Bubali 25g cleaned up, Radix Rehmanniae 35g, Radix Paeoniae Rubra 14g, Cortex Moutan 14g, Radix Salviae Miltiorrhizae 20g, Radix Scrophulariae 20g, Cortex Phellodendri 14g, Rhizoma Smilacis Glabrae 35g, Semen Persicae 12g, Flos Carthami 12g, Radix Angelicae Sinensis 20g mix homogeneously, extract the active component of Chinese medicine, decoct with water 3 times, each 0.5 ~ 1 hour, merge 3 decocting liquids, filter, being condensed into 60 DEG C of relative densities is the thick paste of 1.25 ~ 1.3, after 50 ~ 60 DEG C of dryings, be crushed to 100 object medicated powder, in incapsulating, sterilization obtains capsule product.This product every is heavy 1.5 grams.
Using method: oral medicine of the present invention, one time 5, one day twice, sooner or later each once.
Claims (2)
1. treating a medicine for erythrodermic psoriasis, is prepared by the crude drug of following ratio of weight and number:
Cornu Bubali 15-25 Radix Rehmanniae 25-35 Radix Paeoniae Rubra 10-14 Cortex Moutan 10-14
Radix Salviae Miltiorrhizae 10-20g Radix Scrophulariae 10-20 Cortex Phellodendri 10-14 Rhizoma Smilacis Glabrae 25-35
Semen Persicae 8-12 Flos Carthami 8-12 Radix Angelicae Sinensis 10-20.
2. treat the medicine of erythrodermic psoriasis according to claim 1, wherein the parts by weight of crude drug are:
Cornu Bubali 20g Radix Rehmanniae 30g Radix Paeoniae Rubra 12g Cortex Moutan 12g
Radix Salviae Miltiorrhizae 15g Radix Scrophulariae 15g Cortex Phellodendri 12g Rhizoma Smilacis Glabrae 30g
Semen Persicae 10g Flos Carthami 10g Radix Angelicae Sinensis 15g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410471579.XA CN104208532B (en) | 2014-09-17 | 2014-09-17 | A kind of medicine for treating erythrodermic psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410471579.XA CN104208532B (en) | 2014-09-17 | 2014-09-17 | A kind of medicine for treating erythrodermic psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104208532A true CN104208532A (en) | 2014-12-17 |
| CN104208532B CN104208532B (en) | 2017-11-07 |
Family
ID=52090705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410471579.XA Active CN104208532B (en) | 2014-09-17 | 2014-09-17 | A kind of medicine for treating erythrodermic psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104208532B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343707A (en) * | 2015-11-23 | 2016-02-24 | 济南科纳信息科技有限公司 | Traditional Chinese medicine used for treating erythema annulare centrifugum |
| CN106266832A (en) * | 2016-09-12 | 2017-01-04 | 防城港思创信息技术有限公司 | A kind of erythroderma shape psoriasis treatment medicine |
| CN113952413A (en) * | 2021-11-24 | 2022-01-21 | 南宁市中医医院 | Rhubarb and liquorice lotion for treating skin diseases |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101653562A (en) * | 2009-09-15 | 2010-02-24 | 周大红 | Traditional Chinese medicine for treating erythrodermic psoriasis |
| CN103405718A (en) * | 2013-08-08 | 2013-11-27 | 李盛民 | TCM pill for treating psoriasis |
| CN103505667A (en) * | 2013-08-10 | 2014-01-15 | 马艳春 | Oral traditional Chinese medicine composition for treating psoriasis |
| CN103656323A (en) * | 2013-12-27 | 2014-03-26 | 孙斌 | Traditional Chinese medicine for treating erythroderma-type psoriasis |
-
2014
- 2014-09-17 CN CN201410471579.XA patent/CN104208532B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101653562A (en) * | 2009-09-15 | 2010-02-24 | 周大红 | Traditional Chinese medicine for treating erythrodermic psoriasis |
| CN103405718A (en) * | 2013-08-08 | 2013-11-27 | 李盛民 | TCM pill for treating psoriasis |
| CN103505667A (en) * | 2013-08-10 | 2014-01-15 | 马艳春 | Oral traditional Chinese medicine composition for treating psoriasis |
| CN103656323A (en) * | 2013-12-27 | 2014-03-26 | 孙斌 | Traditional Chinese medicine for treating erythroderma-type psoriasis |
Non-Patent Citations (1)
| Title |
|---|
| 张倩等: "红皮病性银屑病致病因素及治疗方法探讨", 《中国中西医结合皮肤性病学杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343707A (en) * | 2015-11-23 | 2016-02-24 | 济南科纳信息科技有限公司 | Traditional Chinese medicine used for treating erythema annulare centrifugum |
| CN106266832A (en) * | 2016-09-12 | 2017-01-04 | 防城港思创信息技术有限公司 | A kind of erythroderma shape psoriasis treatment medicine |
| CN113952413A (en) * | 2021-11-24 | 2022-01-21 | 南宁市中医医院 | Rhubarb and liquorice lotion for treating skin diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104208532B (en) | 2017-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101530578B (en) | Drug for curing skin scratchness | |
| CN102488879B (en) | Medicinal composition for treating rheumatism | |
| CN102370725A (en) | Traditional Chinese medicine compound preparation for treating chronic pelvic inflammation and preparation method thereof | |
| CN103446567B (en) | Premenstrual ease pharmaceutical composition and preparation technique thereof | |
| CN102512611B (en) | Traditional Chinese medicine for treating recurrent oral ulcer and preparation method | |
| CN102688420B (en) | Traditional Chinese medicine decoction for treating psoriasis | |
| CN101912575B (en) | External medicament for treating painful swelling of joints and gout diseases and preparation process thereof | |
| CN103316174A (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN102614305A (en) | Medicament for treating allergic purpura | |
| CN104208532A (en) | Drug for treating erythrodermic psoriasis | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN103919966B (en) | A kind of medicine treating acne | |
| CN103341037B (en) | Traditional Chinese medicine composition for treating azoospermia | |
| CN101002848B (en) | Medicine for treating recurrent uarthritis, and its preparing method | |
| CN102552520B (en) | Blood circulation-promoting and pain-stopping medicament and preparation process and application thereof | |
| CN105194584A (en) | Medicine for treating dysmenorrhea | |
| CN103156985B (en) | Traditional Chinese medicine composition for treating cyclomastopathy | |
| CN102579677B (en) | Chinese medicinal composition for treating brain glioma | |
| CN103610982A (en) | Medicine for treating rheumatic arthritis | |
| CN1313120C (en) | Application of ciliate bugle herb piece in preparing medicine for treating scapulohumeral periarthritis | |
| CN104043008A (en) | External traditional Chinese medicinal composition for treating myofascitis and preparation method thereof | |
| CN103239655B (en) | Macule-transforming decoction for treating psoriasis | |
| CN103006995B (en) | Medicine for treating post-dural puncture headache (PDPHA) | |
| CN102389506B (en) | Pharmaceutical composition for treating rheumatism and rheumatoid arthritis | |
| CN101884714B (en) | Chinese medicinal decoction for treating urticaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |